256 related articles for article (PubMed ID: 34784943)
1. NMD abnormalities during brain development in the Fmr1-knockout mouse model of fragile X syndrome.
Kurosaki T; Sakano H; Pröschel C; Wheeler J; Hewko A; Maquat LE
Genome Biol; 2021 Nov; 22(1):317. PubMed ID: 34784943
[TBL] [Abstract][Full Text] [Related]
2. Loss of the fragile X syndrome protein FMRP results in misregulation of nonsense-mediated mRNA decay.
Kurosaki T; Imamachi N; Pröschel C; Mitsutomi S; Nagao R; Akimitsu N; Maquat LE
Nat Cell Biol; 2021 Jan; 23(1):40-48. PubMed ID: 33420492
[TBL] [Abstract][Full Text] [Related]
3. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
[TBL] [Abstract][Full Text] [Related]
4. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
[TBL] [Abstract][Full Text] [Related]
5. Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse.
Filippini A; Bonini D; Lacoux C; Pacini L; Zingariello M; Sancillo L; Bosisio D; Salvi V; Mingardi J; La Via L; Zalfa F; Bagni C; Barbon A
RNA Biol; 2017 Nov; 14(11):1580-1591. PubMed ID: 28640668
[TBL] [Abstract][Full Text] [Related]
6. Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.
Amiri A; Sanchez-Ortiz E; Cho W; Birnbaum SG; Xu J; McKay RM; Parada LF
Autism Res; 2014 Feb; 7(1):60-71. PubMed ID: 24408886
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
[TBL] [Abstract][Full Text] [Related]
8. Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome.
Liu ZH; Huang T; Smith CB
Neurobiol Dis; 2012 Mar; 45(3):1145-52. PubMed ID: 22227453
[TBL] [Abstract][Full Text] [Related]
9. BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse.
Louhivuori V; Vicario A; Uutela M; Rantamäki T; Louhivuori LM; Castrén E; Tongiorgi E; Akerman KE; Castrén ML
Neurobiol Dis; 2011 Feb; 41(2):469-80. PubMed ID: 21047554
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
[TBL] [Abstract][Full Text] [Related]
11. Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortex.
Arsenault J; Hooper AWM; Gholizadeh S; Kong T; Pacey LK; Koxhioni E; Niibori Y; Eubanks JH; Wang LY; Hampson DR
Hum Mol Genet; 2021 Feb; 29(23):3744-3756. PubMed ID: 33084871
[TBL] [Abstract][Full Text] [Related]
12. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
[TBL] [Abstract][Full Text] [Related]
13. Cerebral protein synthesis in a knockin mouse model of the fragile X premutation.
Qin M; Huang T; Liu Z; Kader M; Burlin T; Xia Z; Zeidler Z; Hukema RK; Smith CB
ASN Neuro; 2014; 6(5):. PubMed ID: 25290064
[TBL] [Abstract][Full Text] [Related]
14. Synaptic vesicle dynamic changes in a model of fragile X.
Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
Mol Autism; 2016; 7():17. PubMed ID: 26933487
[TBL] [Abstract][Full Text] [Related]
15. Reduced phenotypic severity following adeno-associated virus-mediated Fmr1 gene delivery in fragile X mice.
Gholizadeh S; Arsenault J; Xuan IC; Pacey LK; Hampson DR
Neuropsychopharmacology; 2014 Dec; 39(13):3100-11. PubMed ID: 24998620
[TBL] [Abstract][Full Text] [Related]
16. Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome.
Gruss M; Braun K
Neural Plast; 2001; 8(4):285-98. PubMed ID: 12018775
[TBL] [Abstract][Full Text] [Related]
17. Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
Ruby K; Falvey K; Kulesza RJ
Neuroscience; 2015 Sep; 303():285-98. PubMed ID: 26166728
[TBL] [Abstract][Full Text] [Related]
18. Altered maturation of the primary somatosensory cortex in a mouse model of fragile X syndrome.
Till SM; Wijetunge LS; Seidel VG; Harlow E; Wright AK; Bagni C; Contractor A; Gillingwater TH; Kind PC
Hum Mol Genet; 2012 May; 21(10):2143-56. PubMed ID: 22328088
[TBL] [Abstract][Full Text] [Related]
19. A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.
Holley AJ; Shedd A; Boggs A; Lovelace J; Erickson C; Gross C; Jankovic M; Razak K; Huber K; Gibson JR
Neurobiol Dis; 2022 Aug; 170():105767. PubMed ID: 35588990
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of ultrasonic vocalizations in a mouse model of fragile X syndrome reveals limited, call type specific deficits.
Roy S; Watkins N; Heck D
PLoS One; 2012; 7(9):e44816. PubMed ID: 22984567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
